Investing.com - ATAI Life Sciences BV (NASDAQ: ATAI) reported third quarter EPS of $0.25, $0.45 better than the analyst estimate of $-0.20. Revenue for the quarter came in at $87K versus the consensus estimate of $0.
ATAI Life Sciences BV's stock price closed at $1.15. It is down -27.22% in the last 3 months and down -58.33% in the last 12 months.
ATAI Life Sciences BV saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See ATAI Life Sciences BV's stock price’s past reactions to earnings here.
According to InvestingPro, ATAI Life Sciences BV's Financial Health score is "weak performance".
Check out ATAI Life Sciences BV's recent earnings performance, and ATAI Life Sciences BV's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar